Mutant KRAS as a critical determinant of the therapeutic response of colorectal cancer | Semantic Scholar
Life | Free Full-Text | Integrated Decision-Making in the Treatment of Colon -Rectal Cancer: The Case of KRAS-Mutated Tumors
Colorectal Cancer
Can KRAS Positive Colorectal and Lung Cancer Finally be Targeted? - CancerConnect
The current treatment paradigm for patients with metastatic colorectal... | Download Scientific Diagram
Microsatellite Instability and KRAS Mutation in Stage IV Colorectal Cancer: Prevalence, Geographic Discrepancies, and Outcomes From the National Cancer Database in: Journal of the National Comprehensive Cancer Network Volume 19 Issue 3 (2021)
IJMS | Free Full-Text | Gene Therapy Targeting p53 and KRAS for Colorectal Cancer Treatment: A Myth or the Way Forward?
KRAS testing is a screening of non-responders to anti-EGFR therapy.... | Download Scientific Diagram
Identification of actionable alterations in colorectal cancer are leading to the development of novel treatment strategies - Mayo Clinic
Tumor microenvironment-adjusted prognostic implications of the KRAS mutation subtype in patients with stage III colorectal cancer treated with adjuvant FOLFOX | Scientific Reports
Colorectal Cancer – Treatments | Gastrointestinal Cancer
KRAS mutation: from undruggable to druggable in cancer | Signal Transduction and Targeted Therapy
Clinical characteristics and prognostic value of the KRAS mutation in Chinese colorectal cancer patients - Ye Yuan, Yingting Liu, Ye Wu, Junling Zhang, Chunti Shen, Feng Zhang, Changping Wu, Wenwei Hu, 2021
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer | Molecular Cancer | Full Text
KRAS-Targeted Therapy Doubles as Component of Immunotherapy - NCI
Promising results for a new bowel cancer treatment
Correlation between KRAS, NRAS and BRAF mutations and tumor localizations in patients with primary and metastatic colorectal cancer
Beyond KRAS status and response to anti-EGFR therapy in metastatic colorectal cancer | Pharmacogenomics
Predictive and prognostic biomarkers for targeted therapy in metastatic colorectal cancer. | Semantic Scholar
The current understanding on the impact of KRAS on colorectal cancer - ScienceDirect
Sotorasib shows activity in advanced colorectal cancer with KRAS G12C mutation
